Analyst On Denbury's Acquisition: No Rival Bidders In Sight And Low Chances Of Deal Break, But Risks Remain

Rezvan does not expect to see another bidder emerge for DEN.

The analyst sees the likelihood of the deal-breaking as extremely low.

However, if it does, Rezvan believes DEN's share price could decline by 10% or more, given part of the rationale for being bought was difficulty contesting for the brownfield emitter deals with investment-grade competitors.

The analyst estimates EPS of $4.96 for FY23 and $5.05 for FY24.

Also, Rezvan expects EBITDA of $556.0 million (vs. consensus $575.4 million) for FY23 and $570.0 million (vs. $643.4 million estimate) for FY24.

Price Action: DEN shares are trading higher by 3.54% at $90.60 on the last check Thursday.

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.